skip to the content

Joint Working between Roche and the NHS

At Roche we firmly believe that better patient care can be achieved through Joint Working with the NHS. This is why we support and actively implement the Department of Health guidance on Joint Working

What is Joint Working?

Joint Working is defined in the Department of Health guidance on Joint Working as:

Situations where, for the benefit of patients, one or more pharmaceutical companies and the NHS pool skills, experience and/or resources for the joint development and implementation of patient centred projects and share a commitment to successful delivery

Roche has successfully worked and continues to work alongside national, regional, and local NHS organisations to support and implement developments in healthcare delivery for the benefits of patients

Our Joint Working projects to date have aimed to:

  • Improve quality throughout a patient's healthcare pathway
  • Implement alternative models of care to increase patient access to care
  • Support redesign of disease management services
  • Better use of data to measure healthcare outcomes and reduce inequalities
  • Enable NHS spending to translate into better healthcare outcomes
  • Share good clinical practice across the NHS

All of this we believe can lead to patient benefits – access to quality healthcare services, and better healthcare outcomes.

Below is a list of Joint Working projects Roche is currently involved in. Click on the Executive Summary links below to learn more:

List of Joint Working projects Roche is currently involved in:

Project Title Start Date Organisations involved Executive Summary (PDF)
North Trent Cancer Network Chemotherapy Capacity Planning Tool (C-PORT) March 2008 North Trent Cancer Network and Roche Products Ltd. (47 KB)
Variance in Cancer Care project Jan 2009 National Cancer Intelligence Network and Roche (130 KB)
The breast cancer pathways project Feb 2009 Velindre NHS Trust and Roche (159 KB)
Variance in Cancer Care project Jan 2010 Mount Vernon Cancer Network and Roche (129 KB)
Costed Pathways: estimating cancer spend requirements for London Feb 2010 National Cancer Action Team, North East London Cancer Network, and West London Cancer Network and Roche (65 KB)
Improving One Year Survival in Breast Cancer Patients March 2010 Barking, Havering and Redbridge University Hospitals NHS Trust and Roche (242 KB)
Commissioning for Quality in Rheumatoid Arthritis (CQRA) May 2011 CQRA and Roche (149 KB)
Improving patient care through the better utilisation of medicine benchmarking August 2011 NHS Life Sciences Innovation Delivery Board and Roche (45 KB)
A costed colorectal cancer (CRC) pathway August 2011 Bristol PCT, Avon Somerset & Wiltshire Cancer Services (ASWCS) & Roche Products Limited (RPL) (127 KB)
Service Evaluation Nottingham (management of follicular lymphoma) December 2012 Nottingham University Hospitals (City Campus) & Roche Products Limited (RPL) (54 KB)

Mapping HER 2 testing Pathway across South Wales Cancer Network

 February 2012 The South Wales Cancer Network, Abertawe Bro-Morganwg Health Board & Hywel Dda Health Board & Roche Products Limited (40 KB)

Costing the Central South Coast Cancer Network Lung Cancer Pathway

 March 2012 The Central South Coast Cancer Network & Roche Products Ltd (31 KB)

Best practice commissioning of hepatitis C services

 March 2012 Department of Health, King’s College Hospital, Liverpool Primary Care Trust's, EMSCG, NHS Yorkshire and Humber, Heywood, Middleton and Rochdale PCT, Barts and The London School of Medicine and Dentistry, The Hepatitis C Trust, British Liver Trust, London Specialised Commissioning Group, Health Protection Agency, Nottingham University Hospitals NHS Trust (44 KB)

Service Evaluation at The Royal Marsden NHS Foundation Trust

 April 2012 The Royal Marsden NHS Foundation Trust and Roche Products Limited (47 KB)

Improving Outcomes for Cancer Patients – meeting compliance with the mandated Systemic Anti-Cancer Therapy Datase

 May 2012 Mount Vernon Cancer Network and Roche Products Limited (55 KB)


For further information on existing Joint Working projects or to explore Joint Working opportunities with Roche please contact us.